Lemon Healthcare experienced a remarkable surge of over 61% on its first day of trading on the KOSDAQ. This increase is attributed to strong demand during its initial public offering (IPO) and growing expectations surrounding its medical data platform and artificial intelligence (AI) business expansion, which are based on partnerships with leading hospitals in South Korea.
As of 9:24 AM on July 6, Lemon Healthcare's shares were trading at 16,170 won, up 6,160 won (61.60%) from the initial offering price of 10,000 won, according to the Korea Exchange.
Founded in 2017, Lemon Healthcare specializes in a real-time interactive medical data relay platform that connects hospitals, patients, insurance companies, and pharmaceutical firms. The company has developed its own platform, the Lemon Digital Bridge (LDB), which standardizes, transforms, and relays diverse medical data from various hospitals in real time.
The company operates several services based on this platform, including smart hospital services (LDB-H), medical data relay services (LDB-E), and a medical data processing and analysis platform (LDB-D), thereby building a comprehensive medical data ecosystem.
As of March this year, Lemon Healthcare has secured contracts with 38 out of 47 major hospitals in South Korea, including Seoul National University Hospital, Severance Hospital, and Asan Medical Center, achieving a market share of 80.8%. The company is expanding its operations to general hospitals and small to medium-sized clinics and has also launched a smart hospital service called Lemon TalkTalk, based on KakaoTalk.
In the insurance sector, its claims service, Claim God, has surpassed 1.9 million subscribers and 10 million claims. The company is also involved in the development of the computerized claims system for real insurance, known as Real Insurance 24, enhancing its medical data relay capabilities.
Market analysts are optimistic about the company's growth potential, particularly in expanding its medical AI business following the IPO. Lemon Healthcare currently holds over 100 million medical data records. The company plans to use the funds raised from the IPO to establish infrastructure for distributing and trading AI training medical data and to create a medical AI data marketplace. Additionally, it intends to invest in upgrading its existing platform and developing new digital healthcare services and marketing initiatives.
Investor interest was high during the IPO process. In the institutional demand forecast, 2,233 institutions participated, resulting in a competition ratio of 1,238 to 1, and the offering price was set at the upper end of the desired range at 10,000 won. In the general subscription phase, the competition ratio reached 1,511 to 1, with subscription deposits totaling approximately 3.78 trillion won.
Hong Byeong-jin, CEO of Lemon Healthcare, stated before the listing, "We will solidify our position as a company that connects the medical AI ecosystem by actively building a marketplace for medical AI training data. We aim to expand high-value-added businesses centered around medical data and grow into a globally competitive medical data platform company."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.